MiR-205 Is Progressively Down-Regulated in Lymph Node Metastasis but Fails as a Prognostic Biomarker in High-Risk Prostate Cancer

The treatment of high-risk prostate cancer (HRPCa) is a tremendous challenge for uro-oncologists. The identification of predictive moleculobiological markers allowing risk assessment of lymph node metastasis and systemic progression is essential in establishing effective treatment. In the current st...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kalogirou, Charis, Spahn, Martin, Krebs, Markus, Joniau, Steven, Lerut, Evelyne, Burger, Maximilian, Scholz, Claus-Jürgen, Kneitz, Susanne, Riedmiller, Hubertus, Kneitz, Burkhard
Format: Artigo
Idioma:Inglês
Publicat: Molecular Diversity Preservation International (MDPI) 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3856012/
https://ncbi.nlm.nih.gov/pubmed/24173237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms141121414
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars